The TMIST breast cancer screening trial continues to enroll women during the COVID-19 pandemic. This article describes ways trial leaders and clinical staff are making TMIST available to women in minority communities.
Dr. Christopher Comstock, a radiologist who specializes in breast cancer imaging, talks about the results of clinical trial EA1141 and how it will hopefully give far more women access to a powerful tool in the fight against breast cancer